CD226 and B-cell chronic lymphocytic leukemia: In light of the prominent reduction in the frequency of CD226 in both advanced‐stage and unmutated CLL patients within the EFF CD8+ T cell subpopulation, we compared their frequency in high‐risk CLL patients (Unmutated or Rai III/IV) to HCs.